Benefits of utilizing gene-modified iPSCs for clinical applications Journal Article


Authors: Ellis, J.; Baum, C.; Benvenisty, N.; Mostoslavsky, G.; Okano, H.; Stanford, W. L.; Porteus, M.; Sadelain, M.
Article Title: Benefits of utilizing gene-modified iPSCs for clinical applications
Keywords: nonhuman; letter; gene; embryonic stem cell; gene locus; pluripotent stem cell; oncogene c myc; lmo2 gene
Journal Title: Cell Stem Cell
Volume: 7
Issue: 4
ISSN: 1934-5909
Publisher: Cell Press  
Date Published: 2010-10-08
Start Page: 429
End Page: 430
Language: English
DOI: 10.1016/j.stem.2010.09.010
PROVIDER: scopus
PUBMED: 20887948
DOI/URL:
Notes: --- - "Cited By (since 1996): 2" - "Export Date: 20 April 2011" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Michel W J Sadelain
    583 Sadelain